Ukko is a biotech company focused on improving the lives of millions suffering from food allergies and sensitivities. Utilizing a computational protein design platform, Ukko develops innovative therapeutics that modulate the immune system of allergic patients without triggering allergic reactions. The company is creating a clinically validated map of molecular interactions between allergens and the immune system, which allows for the design of new allergen versions that re-educate the immune system to tolerate these allergens. This unique approach positions Ukko as a leader in the food allergy therapeutics market, addressing a significant healthcare challenge with a potential market impact of $25 billion annually.

Palo Alto, CA, USA

Tel Aviv-Yafo, Israel

Ukko

Innovation Endeavors invests in visionary founders, transformational technology and emergent ecosystems for a new world.

Innovation Endeavors

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Innovation Endeavors Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Innovation Endeavors network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Innovation Endeavors company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Investing in visionary founders, transformational technology and emergent ecosystems for a new world.